Right atrial strain in Anderson-Fabry disease

被引:0
|
作者
Lillo, Rosa [1 ,2 ]
Cianci, Alessio [2 ]
Meucci, Maria Chiara [1 ]
Iannaccone, Giulia [1 ,2 ]
Di Brango, Claudio [2 ]
Tusa, Filippo [2 ]
Marsilia, Mario [2 ]
Lanza, Gaetano Antonio [1 ,2 ]
Lombardo, Antonella [1 ,2 ]
Burzotta, Francesco [1 ,2 ]
Graziani, Francesca [1 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Cardiovasc CUORE, Rome, Italy
[2] UNIV CATTOLICA SACRO CUORE, Fac Med & Chirurg, Dipartimento Sci Cardiovasc CUORE, ROME, Italy
来源
关键词
Anderson-Fabry disease; right atrium; speckle tracking echocardiography; strain; cardiomyopathy; 2-DIMENSIONAL SPECKLE TRACKING; ECHOCARDIOGRAPHY; DYSFUNCTION;
D O I
10.3389/fcvm.2025.1496534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To date, only limited data are available on right atrium (RA) morphofunctional remodeling in Fabry disease (FD). Purpose: We aimed to investigate RA structural and functional remodeling in patients with FD vs. healthy controls using 2D speckle tracking echocardiography (STE) and to explore whether any differences exist in FD patients with and without left ventricular hypertrophy (LVH). Methods: We prospectively enrolled patients with FD and controls matched for age, sex, and cardiovascular risk factors. Patients with FD were divided in two groups according to the presence/absence of LVH (LVH+: left ventricular wall thickness >12 mm). All patients underwent standard echocardiography and STE analysis investigating the mechanics of all cardiac chambers, including RA reservoir, contractile and conduit strain. Results: A total of 64 patients with FD (50% males; mean age 50 +/- 17 years; 51.5% LVH+) and 64 control patients were included in the study. Focusing on right chambers, RA and right ventricular (RV) dimensions were similar between FD and controls. No differences were found for tricuspid annular plane systolic excursion (p = 0.073) and RV fractional area change (p = 0.461), while RV systolic Tissue Doppler velocity was reduced in patients with FD (p = 0.041). STE analysis revealed impaired strain values for all cardiac chambers in FD vs controls, specifically: left ventricular global longitudinal strain (LV-GLS, p < 0.001), left atrial (LA) reservoir strain (p = 0.001), conduit strain (p = 0.012), and contractile strain (p < 0.001), RV-GLS and RV free wall strain (p < 0.001). Similarly, all RA strain phases were significantly reduced in patients with FD compared with control patients (RA reservoir 27.4 +/- 11.1 vs. 41.9 +/- 8.3%, p < 0.001; RA contractile 9.9 +/- 5.1 vs. 18.0 +/- 4.9%, p < 0.001; RA conduit 19.1 +/- 8.1 vs. 24.1 +/- 8.1%, p = 0.001). When comparing FD patients without LVH to controls, it was found that RA reservoir and contractile strains were significantly reduced in the former (p < 0.001). In multivariable linear regression analyses, LA reservoir strain (p = 0.010) and LV-GLS (p = 0.044) emerged as independent correlates of RA mechanics after adjustments were made for RA dimensions, RV systolic function parameters and hypertrophy, and LV maximal wall thickness. Conclusions: In FD impaired RA strain is a common finding. RA reservoir and contractile strains are reduced in FD patients even before LVH ensues, as compared to controls. LA reservoir strain and LV-GLS show an independent correlation with RA reservoir strain.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Anderson-Fabry disease in AustriaMorbus Fabry in Österreich
    Matthias Lorenz
    Anna-Christina Hauser
    Margot Püspök-Schwarz
    Peter Kotanko
    Ingrid Arias
    Herbert Zodl
    Reinhard Kramar
    Eduard Paschke
    Till Voigtländer
    Gere Sunder-Plassmann
    Wiener Klinische Wochenschrift, 2003, 115 : 235 - 240
  • [22] Anderson-Fabry disease in children and adolescents
    Beck, M
    Whybra, C
    Wendrich, K
    Gal, A
    Ries, M
    RARE KIDNEY DISEASES, 2001, 136 : 251 - 255
  • [23] Anderson-Fabry disease in heart failure
    Akhtar M.M.
    Elliott P.M.
    Biophysical Reviews, 2018, 10 (4) : 1107 - 1119
  • [24] Otology manifestations of the Anderson-Fabry disease
    Pomar Blanco, P.
    Roman Carbajo, J. San
    Martin Villares, C.
    Rodriguez Martin, F.
    Paniagua, J.
    Fernandez Pello, M.
    Tapia Risueno, M.
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2006, 57 (02): : 115 - 117
  • [25] Gastroenterological Complications of Anderson-Fabry Disease
    Buda, Piotr
    Ksiazyk, Janusz
    Tylki-Szymanska, Anna
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 6009 - 6013
  • [26] Gene Therapy of Anderson-Fabry Disease
    Tuttolomondo, Antonino
    Simonetta, Irene
    Pinto, Antonio
    CURRENT GENE THERAPY, 2019, 19 (01) : 3 - 5
  • [27] Renal involvement in Anderson-Fabry disease
    Sessa, A
    Meroni, M
    Battini, G
    Righetti, M
    Maglio, A
    Tosoni, A
    Nebuloni, M
    Vago, G
    Giordano, F
    JOURNAL OF NEPHROLOGY, 2003, 16 (02) : 310 - 313
  • [28] Misleading terms in Anderson-Fabry disease
    Weidemann, F.
    Strotmann, J. M.
    Breunig, F.
    Niemann, M.
    Maag, R.
    Baron, R.
    Eggert, A. O.
    Wanner, C.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (03) : 191 - 196
  • [29] Hypertrophic cardiomyopathy in Anderson-Fabry disease
    Cecchi, Franco
    Frullini, Anna
    Olivotto, Iacopo
    Castelli, Gabriele
    Ciaccheri, Mauro
    Martinelli, Fabrizio
    Torricelli, Francesca
    Borsini, Walter
    Garbini, Francesca
    CLINICAL THERAPEUTICS, 2007, 29 : S93 - S94
  • [30] The Cardiovascular Manifestations of Anderson-Fabry Disease
    Adeboye, Adedayo
    Alkhatib, Deya
    Latham, Samuel
    Jefferies, John
    CURRENT CARDIOVASCULAR RISK REPORTS, 2022, 16 (06) : 43 - 51